The trading price of Conduit Pharmaceuticals Inc (NASDAQ:CDT) closed higher on Tuesday, July 08, and closing at $2.46, 1.65% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $2.33 and $2.49. In examining the 52-week price action we see that the stock hit a 52-week high of $892.20 and a 52-week low of $2.21. Over the past month, the stock has lost -8.89% in value.
Conduit Pharmaceuticals Inc, whose market valuation is $1.86 million at the time of this writing, is expected to release its quarterly earnings report in August. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest CDT has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that CDT’s price is currently -2.13% off the SMA20 and -43.17% off the SMA50. The RSI metric on the 14-day chart is currently showing 35.20, and weekly volatility stands at 8.59%. When measured over the past 30 days, the indicator reaches 8.95%. Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s beta value is currently sitting at 1.94.
To see how Conduit Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: CDT stock’s performance was 1.65% in the latest trading, and -97.61% in the past year.
An evaluation of the daily trading volume of Conduit Pharmaceuticals Inc (NASDAQ:CDT) indicates that the 3-month average is 437.20K. However, this figure has increased over the past 10 days to an average of 0.64.
Currently, records show that 0.76 million of the company’s shares remain outstanding. The insiders hold 1.46% of outstanding shares, whereas institutions hold 4.54%. The stats also highlight that short interest as of 2025-06-13, stood at 0.1 million shares, resulting in a short ratio of 0.22 at that time. From this, we can conclude that short interest is 1284.00 of the company’s total outstanding shares. It is noteworthy that short shares in June were up slightly from the previous month’s figure, which was 51021.0. However, since the stock’s price has seen -99.74% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
